147 related articles for article (PubMed ID: 12219782)
1. Location-guided screening of liquid-based cervical cytology specimens: a potential improvement in accuracy and productivity is demonstrated in a preclinical feasibility trial.
Wilbur DC; Parker EM; Foti JA
Am J Clin Pathol; 2002 Sep; 118(3):399-407. PubMed ID: 12219782
[TBL] [Abstract][Full Text] [Related]
2. FocalPoint slide classification algorithms show robust performance in classification of high-grade lesions on SurePath liquid-based cervical cytology slides.
Parker EM; Foti JA; Wilbur DC
Diagn Cytopathol; 2004 Feb; 30(2):107-10. PubMed ID: 14755762
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of AutoPap system location-guided screening in the evaluation of cervical cytology smears.
Stevens MW; Milne AJ; Parkinson IH; Nespolon WW; Fazzalari NL; Arora N; Dodd TJ
Diagn Cytopathol; 2004 Aug; 31(2):94-9. PubMed ID: 15282720
[TBL] [Abstract][Full Text] [Related]
4. A feasibility study of the AutoPap system location-guided screening.
Lee JS; Kuan L; Oh S; Patten FW; Wilbur DC
Acta Cytol; 1998; 42(1):221-6. PubMed ID: 9479344
[TBL] [Abstract][Full Text] [Related]
5. The AutoPap system for primary screening in cervical cytology. Comparing the results of a prospective, intended-use study with routine manual practice.
Wilbur DC; Prey MU; Miller WM; Pawlick GF; Colgan TJ
Acta Cytol; 1998; 42(1):214-20. PubMed ID: 9479343
[TBL] [Abstract][Full Text] [Related]
6. Sensitivity studies of AutoPap System Location-Guided Screening of cervical-vaginal cytologic smears.
Huang TW; Lin TS; Lee JS
Acta Cytol; 1999; 43(3):363-8. PubMed ID: 10349363
[TBL] [Abstract][Full Text] [Related]
7. Impact of the AutoPap (currently Focalpoint) primary screening system location guide use on interpretation time and diagnosis.
Ronco G; Vineis C; Montanari G; Orlassino R; Parisio F; Arnaud S; Berardengo E; Fabbrini T; Segnan N
Cancer; 2003 Apr; 99(2):83-8. PubMed ID: 12704687
[TBL] [Abstract][Full Text] [Related]
8. Liquid-based cervical cytology.
Klinkhamer PJ; Meerding WJ; Rosier PF; Hanselaar AG
Cancer; 2003 Oct; 99(5):263-71. PubMed ID: 14579292
[TBL] [Abstract][Full Text] [Related]
9. The Becton Dickinson FocalPoint GS Imaging System: clinical trials demonstrate significantly improved sensitivity for the detection of important cervical lesions.
Wilbur DC; Black-Schaffer WS; Luff RD; Abraham KP; Kemper C; Molina JT; Tench WD
Am J Clin Pathol; 2009 Nov; 132(5):767-75. PubMed ID: 19846820
[TBL] [Abstract][Full Text] [Related]
10. Assisted primary screening using the automated ThinPrep Imaging System.
Biscotti CV; Dawson AE; Dziura B; Galup L; Darragh T; Rahemtulla A; Wills-Frank L
Am J Clin Pathol; 2005 Feb; 123(2):281-7. PubMed ID: 15842055
[TBL] [Abstract][Full Text] [Related]
11. Usefulness of liquid-based cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials.
Yoshida T; Fukuda T; Sano T; Kanuma T; Owada N; Nakajima T
Cancer; 2004 Apr; 102(2):100-8. PubMed ID: 15098254
[TBL] [Abstract][Full Text] [Related]
12. [New techniques in cytology: liquid milieu and thin slides].
Joris F; Richard J; Tötsch M
Rev Med Suisse Romande; 1999 Oct; 119(10):793-8. PubMed ID: 10582491
[No Abstract] [Full Text] [Related]
13. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer.
Nieminen P; Vuorma S; Viikki M; Hakama M; Anttila A
BJOG; 2004 Aug; 111(8):842-8. PubMed ID: 15270934
[TBL] [Abstract][Full Text] [Related]
14. Automated prescreening of conventionally prepared cervical smears: a feasibility study.
Bartoo GT; Lee JS; Bartels PH; Kiviat NB; Nelson AC
Lab Invest; 1992 Jan; 66(1):116-22. PubMed ID: 1731146
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of PAPNET--a semiautomated system used in the screening against cervical cancer].
Hølund B; Ejersbo D; Hjortebjerg A
Ugeskr Laeger; 1998 Sep; 160(40):5802-6. PubMed ID: 9782761
[TBL] [Abstract][Full Text] [Related]
16. A feasibility study of the use of the AutoPap screening system as a primary screening and location-guided rescreening device.
Confortini M; Bonardi L; Bulgaresi P; Cariaggi MP; Cecchini S; Ciatto S; Cipparrone I; Galanti L; Maddau C; Matucci M; Rubeca T; Troni GM; Turco P; Zappa M; Carozzi F
Cancer; 2003 Jun; 99(3):129-34. PubMed ID: 12811852
[TBL] [Abstract][Full Text] [Related]
17. Multicenter masked evaluation of AutoCyte PREP thin layers with matched conventional smears. Including initial biopsy results.
Bishop JW; Bigner SH; Colgan TJ; Husain M; Howell LP; McIntosh KM; Taylor DA; Sadeghi MH
Acta Cytol; 1998; 42(1):189-97. PubMed ID: 9479339
[TBL] [Abstract][Full Text] [Related]
18. Liquid-based cytology for cervical cancer screening.
Bentz JS
Expert Rev Mol Diagn; 2005 Nov; 5(6):857-71. PubMed ID: 16255628
[TBL] [Abstract][Full Text] [Related]
19. [The use of a computerised system in the reading of cytological cervicovaginals smears during programming of regional screening (one year of experience using the autopap system)].
Orlassino R; Fabbrini T; Gallo C; Vineis C
Pathologica; 2005 Apr; 97(2):78-83. PubMed ID: 16032952
[TBL] [Abstract][Full Text] [Related]
20. Use of automated primary screening on liquid-based, thin-layer preparations.
Vassilakos P; Carrel S; Petignat P; Boulvain M; Campana A
Acta Cytol; 2002; 46(2):291-5. PubMed ID: 11917575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]